This review highlights the evolving landscape of catheter-based treatments for mitral regurgitation, including edge-to-edge repair and percutaneous annuloplasty.
Answers are grounded in this paper and cite their sources.
Supports exploration of percutaneous mitral repair; leaves open comparative efficacy and durability versus surgery.
Mitral Regurgitation (MR) is a common medical problem. MR is also a prognostic factor; patients with severe symptomatic MR have a poor prognosis with an annual mortality rate of 5% without surgical intervention. An anatomic understanding of the normal and regurgitant mitral valve is essential in order to evaluate appropriately the severity and impact of MR. We briefly discuss mitral complex anatomy, MR evaluation, and treatment options (surgical and catheter-based alternatives) according to the type of lesion found. In particular, our group has shown temporal percutaneous annuloplasty and definitive percutaneous edge-to-edge mitral valve repair to be a feasible technique. Recently a study evaluating endovascular mitral valve edge-to-edge repair was successfully initiated by our group. Acute and chronic ischemic mitral regurgitation and special situations, such as paravalvular leaks, hypertrophic obstructive cardiomyopathy, and mixed lesions are also discussed. Future directions may include the percutaneous transcatheter implantation of a bioprosthetic valve in mitral position.
No takes yet. Share an insight, caveat, or question.
Condado et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: